Email ID
Password
Scrip   
Celgene and Innate Pharma to collaborate on clinical multiple myeloma study
19 November 2009
Sukaina Virji

Celgene of the US is to collaborate with the French firm Innate Pharma to evaluate the potential for clinical synergy of a combination treatment of Celgene's Revlimid (lenalidomide) with Innate's investigational treatment, IPH 2101, in patients with multiple myeloma who have failed first-line therapy.

The...



Please Login to read the full article.
EVENTS
Today
Cambridge, UK
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36